Receptors in asthmatic airways

Area of Science:

• Pulmonary Medicine
• Pharmacology
• Cell Biology

Background:

• Asthma pathophysiology involves complex receptor system alterations.
• Understanding receptor dysfunction is crucial for asthma treatment.
• Human airway research is vital, as animal models may not fully represent human responses.

Purpose of the Study:

• Investigate receptor system roles in severe asthma.
• Examine airway smooth muscle contractility and receptor function.
• Characterize the distribution and function of specific receptors in human asthmatic airways.

Main Methods:

• Postmortem analysis of human lung tissue (non-diseased and asthmatic).
• Functional, radioligand binding, and autoradiographic studies.
• Assessment of histamine H1, muscarinic cholinoceptor, alpha 1, and beta-adrenoceptors.
• Investigation of airway epithelium-derived inhibitory factor (EpDIF) release.
• Autoradiographic localization of substance P (SP) binding sites.

Main Results:

• Asthma does not show intrinsic smooth muscle abnormality to spasmogens.
• No evidence of up-regulation for histamine H1, muscarinic, or alpha 1-adrenoceptors.
• Severe asthma exhibits significant beta-adrenoceptor dysfunction, possibly due to uncoupling from adenylate cyclase.
• Histamine and methacholine induce EpDIF release, potentially having a dilator effect.
• Reduced EpDIF activity expected in asthma due to epithelium damage.
• Substance P binding is sparse on human airway smooth muscle but dense in submucosal glands and beneath the epithelium.

Conclusions:

• Beta-adrenoceptor dysfunction is a key feature of severe asthma, linked to airway inflammation.
• Airway epithelium-derived inhibitory factor (EpDIF) may play a protective role, but its activity is likely reduced in asthma.
• Substance P's role in human bronchi appears more related to secretion than smooth muscle contraction.
• Findings emphasize the limitations of animal models for human airway research.